Last reviewed · How we verify

Sertaconazole nitrate cream 2% — Competitive Intelligence Brief

Sertaconazole nitrate cream 2% (Sertaconazole nitrate cream 2%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Imidazole antifungal. Area: Dermatology.

phase 3 Imidazole antifungal Lanosterol 14α-demethylase (CYP51) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Sertaconazole nitrate cream 2% (Sertaconazole nitrate cream 2%) — Jamaica Hospital Medical Center. Sertaconazole nitrate inhibits fungal cell membrane ergosterol synthesis by blocking lanosterol 14α-demethylase, disrupting fungal growth and viability.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sertaconazole nitrate cream 2% TARGET Sertaconazole nitrate cream 2% Jamaica Hospital Medical Center phase 3 Imidazole antifungal Lanosterol 14α-demethylase (CYP51)
Monistat miconazole Johnson & Johnson (Janssen) marketed Imidazole antifungal 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6 1974-01-01
Topical ketoconazole 2% cream Topical ketoconazole 2% cream PAEC General Hospital, Islamabad marketed Imidazole antifungal Fungal cytochrome P450 (CYP51 / lanosterol 14α-demethylase)
Topical Sertaconazole 2% Topical Sertaconazole 2% Jinnah Postgraduate Medical Centre marketed Imidazole antifungal Lanosterol 14α-demethylase (CYP51)
Nizoral® Nizoral® Ache Laboratorios Farmaceuticos S.A. marketed Imidazole antifungal Lanosterol 14α-demethylase (CYP51)
Topical Clotrimazole cream Topical Clotrimazole cream Hayat Abad Medical Complex, Peshawar marketed Imidazole antifungal Fungal lanosterol 14α-demethylase (CYP51)
Miconazole Nitrate 2% Miconazole Nitrate 2% Aesculape CRO Belgium BV marketed Imidazole antifungal Lanosterol 14α-demethylase (CYP51)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Imidazole antifungal class)

  1. Galderma R&D · 2 drugs in this class
  2. Bayer · 2 drugs in this class
  3. AmDerma · 2 drugs in this class
  4. Jinnah Postgraduate Medical Centre · 2 drugs in this class
  5. Ache Laboratorios Farmaceuticos S.A. · 2 drugs in this class
  6. Jamaica Hospital Medical Center · 1 drug in this class
  7. Johnson & Johnson (Janssen) · 1 drug in this class
  8. Laboratoire Innotech International · 1 drug in this class
  9. PAEC General Hospital, Islamabad · 1 drug in this class
  10. Peking University Shenzhen Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sertaconazole nitrate cream 2% — Competitive Intelligence Brief. https://druglandscape.com/ci/sertaconazole-nitrate-cream-2. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: